Delivery Order SPE2DB24D2101-SPE2DB25FKLLC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,571.33 to AmerisourceBergen Drug Corp for the supply of Zepbound (tirzepatide) 10 mg/0.5 mL pens on April 23, 2025, with completion scheduled for April 24, 2025. This competitive award, issued on a firm fixed-price basis without set-aside designation, represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at...
- The Defense Logistics Agency awarded a $2,045.91 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Zepbound (tirzepatide) 5 mg/0.5 mL pen injectors. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Zepbound is a diabetes and weight management medication, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $35,643.13 to AmerisourceBergen Drug Corp for the supply of Zepbound (tirzepatide) 7.5 mg/0.5 mL pens on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitive, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zepbound (tirzepatide) 10 mg/0.5 mL in pen form, with a ceiling value of $3,762.89. The award, issued on August 28, 2025, with an ultimate completion date of August 29, 2025, utilizes firm fixed pricing under a non-competitive set-aside structure. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of...
- The Defense Logistics Agency awarded a delivery order valued at $14,950.78 to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Zepbound (tirzepatide) 15 mg/0.5 mL pen injectors. This competitively awarded, firm fixed-price contract is scheduled for completion by July 24, 2025, with performance taking place at AmerisourceBergen's corporate offices in Conshohocken, Pennsylvania. The contract represents a single delivery order issued under a larger procurement vehicle and carries...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Zepbound (tirzepatide) 15 mg/0.5 mL pens valued at $1,313.30. This firm fixed price delivery order, which will be completed by August 27, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The award is classified as a non-set-aside procurement and was performed at the company's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at approximately $43.3K to AmerisourceBergen Drug Corp for the supply of Zepbound (tirzepatide) 5 mg/0.5 mL pens on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zepbound (tirzepatide) 5 mg/0.5 mL pens valued at $8,763.90. This contract represents a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and will be fulfilled at the contractor's Conshohocken, Pennsylvania facility. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's competitive...
- The Defense Logistics Agency awarded a $13,027.34 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Zepbound (tirzepatide) 15 mg/0.5 ml pens, with an ultimate completion date of September 4, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $3,812.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Zepbound (tirzepatide) 15 mg/0.5 mL injection pens. The delivery order, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, carries an ultimate completion date of September 22, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This award...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKLLCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,740.83 to AmerisourceBergen Drug Corp for the supply of Zepbound (tirzepatide) 15 mg/0.5 mL pens on June 16, 2025, with completion targeted for June 17, 2025. This non-competitive delivery order represents a firm fixed-price transaction executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a FDA-approved GLP-1 receptor agonist used in diabetes and weight management treatment, reflecting the Defense Health Agency's pharmaceutical procurement needs for military healthcare systems. This delivery order is a child contract under AmerisourceBergen's comprehensive pharmaceutical prime vendor agreement with the Defense Logistics Agency, which enables the company to supply a broad range of brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen maintains an extensive portfolio of delivery orders with DLA covering multiple therapeutic domains. The pharmaceutical prime vendor program structure allows the Defense Logistics Agency to efficiently procure essential medications through a flexible contracting mechanism while leveraging AmerisourceBergen's established distribution capabilities and supply chain infrastructure to serve military beneficiaries and healthcare facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 6/16/25 |